Lilly’s obesity drug looks more potent than Novo’s in observational study

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Good morning. STAT published an investigation this morning on the untold story of the Human Genome Project and ethics concerns surrounding the ambitious project. Check it out here.

Read the rest…

Read Original Article: Lilly’s obesity drug looks more potent than Novo’s in observational study »